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Abstract
Filamin-A (FLNa) has been shown to be a key cross-linker of actin filaments in the leading edge of a motile
melanoma cell line, however its role in neutrophils undergoing chemotaxis is unknown. Using a murine transgenic
model in which FLNa is selectively deleted in granulocytes, we report that, while neutrophils lacking FLNa show
normal polarization and pseudopod extension, they exhibit obvious defects in uropod retraction. This uropod
retraction defect was found to be a direct result of reduced FLNa mediated activation of the small GTPase RhoA and
myosin mediated actin contraction in the FLNa null cells. This results in a neutrophil recruitment defect in FLNa null
mice. The compensatory increase in FLNb levels that was observed in the FLNa null neutrophils may be sufficient to
compensate for the lack of FLNa at the leading edge allowing for normal polarization, however this compensation is
unable to regulate RhoA activated tail retraction at the rear of the cell.
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Introduction
Cell migration is a fundamental process in a diverse array of
physiologic processes, including organism development,
wound healing, and immune function. This central cellular
event involves a progression through a repeating set of
coordinated steps; extension of the leading edge
(lamellopodium), attachment of the leading edge to the
substratum, forward flow of the cytosol, and retraction of the
rear of the cell (uropod). In order for coordinated forward cell
movement to occur, these steps must be carried out in an
orderly, sequential and repeating manner. Identifying the
various elements regulating these various steps is critical to the
understanding of cell migration.
The neutrophil is an excellent model system for studying cell
migration and chemotaxis, since these highly motile cells
display a very well-defined polarity during chemotaxis that
allows for the visualization of the fluid transitions between the
steps of cell migration. Initially, using fibroblasts and now
neutrophils, it has been shown that members of the Rho
GTPase family including Rac, cdc42, and RhoA play crucial
roles during cell migration [1,2]
While Cdc42 is responsible for filopodia formation and cell
polarity, Rac localizes to, and is necessary for, efficient actin
polymerization and protrusion of the leading edge [2,3]. Rho on
the other hand, localizes to the rear of the migrating cell and is
necessary for myosin-based contraction of the cell’s uropod or
trailing edge [1,3,4].
Actin binding proteins regulate cell migration through
activation of actin filament assembly and disassembly. They
are also key regulators of the actin cytoskeletal architecture/
morphology. Filamin family members are critical regulators of
the actin cytoskeletal architecture [5] . These large cytoplasmic
proteins cross link actin filaments into orthogonal three-
dimensional networks in the actin cortex. The three human
isoforms; Filamin A (FLNa), Filamin B (FLNb) and Filamin C
(FLNc) share 70% sequence homology, although they have
unique tissue expression with both FLNa and FLNb being
ubiquitously expressed, while FLNc shows more restricted
expression limited to skeletal and cardiac muscles during adult
life.
The prototype and first identified filamin, FLNa, was
discovered in monocyte/macrophages and shown to be a
potent cross linker of actin filaments in the cell cortex [6] .
Through its ability to crosslink actin filaments into highly
branched (orthangonal) networks, it is able to stabilize actin
filaments in the leading edge of migrating cells thereby
facilitating efficient cell migration [5-7]. Previous studies
investigating FLNa’s role in cell migration have been primarily
carried out in human melanoma cells lacking the FLNa protein.
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These FLNa null cells display severe impairments in the
earliest stages of cell locomotion; namely cell polarization and
pseudopod extension which manifests as continuous
circumferential blebbing of the plasma membrane [8]. However,
more recently, FLNa has also been shown to be an important
integrator of signals in a large variety of cellular processes
through its binding to many signaling proteins including the Rho
family of small GTPases[ 5,9].
RhoA, along with the other members of the Rho GTPases,
functions as a molecular switch, cycling between an inactive
GDP-bound state and an active GTP bound state. Their state
of activity is regulated by the opposing effects of guanine
nucleotide exchange factors (GEFs), which enhance the GTP
bound form, and the GTPase-activating proteins (GAPs), which
increase the intrinsic rate of hydrolysis of bound GTP [2,10,11].
We and others have previously shown that Rho activity is
required in the uropod in order to carryout coordinated uropod
retraction during chemotaxis[12]. In this study, we demonstrate
that FLNa plays an essential role in the activation of the RhoA
small GTPase and myosin based uropod contraction during
neutrophil chemotaxis.
Materials and Methods
FLNa Mutant Mice
All procedures were carried out in accordance with the Guide
for the Humane Use and Care of Laboratory Animals, and were
approved by the University of Toronto Animal Care Committee.
Mice containing the conditional knock out of the X-linked
FLNa gene were generated as described previously [13].
Briefly, a conditional knockout strategy was used with loxp sites
inserted into introns 2 and 7 of the mouse FLNa gene (FLNac/c
or male FLNa c/y mice). In order to target deletion of the FLNa
gene to neutrophils these mice were bred with mice expressing
cre recombinase under control of the LysM promoter which is
granulocyte specific [14]. The LysM gene encodes lysozyme,
an enzyme that is expressed at high levels in granulocyte
precursor cells. Cre-mediated recombination deletes exons
3-7, producing a non-sense mutation with early FLNa
truncation at amino acid 121. We have previously
demonstrated that this results in >90% deletion of the floxed
gene in neutrophils [15-17].
PCR Genotyping Analyses of Mice
Tail snips were used to prepare DNA for PCR analysis [18].
PCR genotyping was performed by simultaneous amplification
of the wild-type (FLNa+), conditional (FLNac), and null (FLNa-)
alleles using four primers: mFNhe5,
TCTTCCTCTTTCAGCTGG; mFBam3,
ACAACTGCTGCTCCAGAG; Syn 1,
CTGCATTACCGGTCGATGCA; Syn
2,ACGTCCACCGGCATCAACGT. mFNhe5 and mFBam3 were
included in a single PCR and yielded products of sizes 270 bp
(FLNa+) and 260 bp (FLNa-), which were analyzed on 3%
agarose gels (Figure 1A). The presence of the LysMcre allele
was assessed by a PCR using primers: Syn 1and Syn 2 which
yielded a product of size 300 bp, described previously [14].
FLNa and FLNb Analysis
Isolated bone marrow neutrophils (40,000 PMNs for each
genotype) were exposed to fMLP (10-6M) (Sigma, St. Louis,
MO) at 37°C for the 2 minutes, immediately lysed with laemmli
buffer, boiled for 10 minutes, and subjected to 7.5% SDS-
PAGE and immunoblotted with either Anti-FLNa or Anti-
FLNb[19]. 1:100 with 5% BSA Tris-buffered saline-Tween
(TBS-T) at 4°C overnight. Membranes were washed 3 times for
10 minutes with TBS-T followed by incubation with goat anti-
mouse IgG peroxidase conjugates (Amersham Pharmacia
Biotech, Buckinghamshire, England). Densitometry analysis of
the Antigen-antibody complexes was carried out. Two standard
curves were created with known amounts of the FLNa (5, 10,
20, 40 ng) and FLNb protein (2ng, 4ng, 6ng, 8ng) as a means
to determine the total protein concentrations in wild-type and
FLNa null neutrophils.
Neutrophil preparations
Mice were killed by CO2 inhalation. Femurs and tibias were
removed and bone marrow was isolated. Bone marrow cells
were layered onto discontinuous Percoll (Sigma, Oakville, ON,
Canada) gradients of 82%/65%/55%. Mature neutrophils were
recovered at the 82%/65% interface and were positive for Gr-1
and Mac-1 as shown by flow cytometry. More than 85% of the
cells isolated were neutrophils, as assessed by Wright-Giemsa
staining [20]. Viability, as determined by trypan blue exclusion,
was more than 90%.
Chemotaxis Assay
Bone marrow neutrophils were suspended in HBSS and 1%
gelatin. A neutrophil suspension (1 x 106/mL) was allowed to
attach to bovine serum albumin (BSA) (1mg/ml)-coated glass
Figure 1.  Genotyping and FLNa Expression.  (A) PCR
confirmation of FLNa in peritoneal neutrophils. Primer mFNhe5
and mFBam3 yielded products of sizes 270 bp representing the
wild-type gene product (lanes 1, 2 and 3), while mFNhe5 and
Mf1Ne8R yielded products of sizes of 260 bp representing the
FLNa null gene product (lanes 4, 5 and 6). Note a small
residual band in the cre recombinase expressing mice. (B)
Representative immunoblot of FLNa expression in peritoneal
neutrophils. As expected from PCR genotyping mice were
generated with neutrophils lacking FLNa expression
designated as FLNa null (lanes 4, 5 and 6). Note the presence
of a faint residual band of FLNa in lanes 4, 5 and 6 which
suggests that the LysM Cre mouse incompletely eliminates the
flanked loxP DNA from all neutrophils. Antibody against β-actin
was used as a loading control. c/c denotes that the FLNa gene
is floxed and conditional. Since the FLNa gene is on the X
chromosome males are denoted with a single c.
doi: 10.1371/journal.pone.0079009.g001
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coverslips (22 x 40 mm) at 37°C for 10 minutes. The coverslip
was inverted into a Zigmond chamber, and 100 µL HBSS
media was added to the right chamber with 100 µL HBSS
media containing fMLP[10-6M] added to the left chamber. Time-
lapse video microscopy was used to examine neutrophil
movements in Zigmond chambers. The microscope (Nikon
Eclipse E400) was equipped with differential interference
contrast optics and X 40 objective. Images were captured at
20-second intervals with Nikon Eclipse E1000 Microscope.
Cell-tracking software (Retrac version 2.1.01 Freeware) was
used to characterize cellular chemotaxis from the captured
images. Image J software was used to measure the length of
cells. Data came from three independent experiments.
Chemokinesis Assay
The procedure was the same as the chemotaxis assay but
100 µL HBSS media containing fMLP[10-6M] was added to the
right and left chambers. Data of the mean value came from
three independent experiments.
Neutrophil polarization without fMLP
A neutrophils suspension in HBSS (1x 106/ml ) were allowed
to attach on BSA(1 mg/ml) coated cover glasses for 15
minutes; images were captured with Nikon Eclipse E1000
Microscope. Three independent experiments were performed.
In vivo chemotaxis and peritonitis model
1 ml (2 mM) sodium periodate was injected into murine
peritoneal cavities. After 3 hours, mice were euthanized with
CO2. PBS media (5 ml) was injected into the murine peritoneal
cavities and the lavage fluid was recollected. The fluid was
centrifuged at 150g for 5 min at 4 °C and cell pellets were
resuspended in PBS. The total number of cell was counted with
Beckman Coulter. Cell monolayers from the peritoneal cavity
prepared using Cytospin 2 (Shandon Southern Products,
Astmoor, UK). Cell morphology was determined on the slides
stained with Diff-Quick (Fisher Scientific, Pittsburgh, PA). Three
independent experiments were carried out.
GST-Pull down
The Pak-binding domain (PBD) and Rhotekin-binding
domain (RBD) assays were carried out as described previously
[21]. Briefly, isolated bone marrow neutrophils were exposed to
fMLP at 37°C for the indicated period of time. They were
immediately lysed, and glutathione-S-transferase (GST)-PBD
or GST-RBD beads (Amersham Pharmacia Biotech
Buckinghamshire, England) was added to the lysates. The
GST-PBD or GST-RBD were recovered with Sepharose beads
and immunoblotting was completed using either a Cdc42
antibody (B-8; Santa Cruz Biotechnology), Rac1 antibody
(Upstate Cell Signaling Solutions (Charlottesville, VA), or a
RhoA antibody (sc-418; Santa Cruz Biotechnology). Image J
software version 1.31v (National Institutes of Health) was used
for blot densitometry. Data was normalized to resting wild-type
neutrophils and are expressed as the mean value from 3
separate experiments.
Phospho-myosin light chain 2 Assay
Isolated bone marrow neutrophils were exposed to fMLP
(10-6M) at 37°C for 120 seconds, immediately lysed with
laemmli buffer, boiled for 10 minutes, and subjected to 15%
SDS-PAGE. Membranes were blocked and immunoblotted with
Phospho-Myosin Light Chain 2 (Ser19) antibody (Cell Signaling
Technology; Beverly, MA) 1:1000 with 5% BSA Tris-buffered
saline-Tween (TBS-T) at 4°C overnight. Membranes were
washed 3 times for 10 minutes with TBS-T followed by
incubation with goat anti-Rabbit IgG peroxidase conjugates
(Amersham Pharmacia Biotech, Buckinghamshire, England).
Antigen-antibody complexes were visualized on X-ray film by
enhanced chemiluminescence (ECL; Perkin Elmer Life
Sciences, Boston, MA). Data is from four separate
experiments.
Phospho-Myosin Light Chain 2, Rho A & FLNa
Immunostaining
One million neutrophils were attached on BSA-coated slides
for 10 min at 37°C and stimulated with fMLP for 2 minutes
followed by fixation with 4% PFA. Fixed cells were washed in
PBS, permeabilized with 0.1% Triton X-100 in PBS for 4
minutes, and blocked with 1% BSA for 30 minutes. Cells were
incubated with anti- Phospho-Myosin Light Chain 2, RhoA (Cell
Signaling Technology) or FLNa, diluted 1:100, and detected
with Alexa Flour 488 goat anti–rabbit IgG (Invitrogen). Cells
were also stained with 1:400 rhodamine phalloidin at room
temperature for 30 min followed by epifluorescence microscopy
analysis. Images were visualized using an Eclipse E100
(Nikon), a 40/0.95 Plan Apo objective (Nikon), and a digital
camera (C4742-80; Hamamatsu). Images were acquired using
Simple PCI software version 5.3 (Compix). Three independent
experiments were carried out.
Cell Adhesion Assay
Aliquotes of 5x105 neutrophils were plated into a 96 wells
plate coated with BSA (100mg/ml), fibronectin(1 mg/ml,
10µg/ml) or fibrinogen( 50µg/ml) for 30 minutes. The total
number of cells was counted under microscope before turning
over the plate and spinning at 33 g for 30 seconds. The wells
were rinsed with PBS and the total number of cells was
counted again. The percentage of adherent cells before and
after spinning was determined. Data was from three
independent experiments.
Statistical Analysis
Data are presented as the mean ± SD. Statistical
comparisons were made by a two-tailed t-test. In cases with
multiple comparisons ANOVA with Tukey for post-hoc testing
was carried out. Blots and micrographs are representative of at
least three separate experiments. Differences with P values ≤
0.05 were considered statistically significant.
Filamin-A Regulates PMN Uropod Retraction via RhoA
PLOS ONE | www.plosone.org 3 October 2013 | Volume 8 | Issue 10 | e79009
Results
Generation of mice with neutrophils lacking FLNa
expression
To directly study the specific roles of Filamin-A (FLNa) during
neutrophil chemotaxis, we bred FLNa conditional mice with
mice expressing cre recombinase downstream of the
graunulocyte specific LysM promoter. Previous studies have
shown that the LysMcre allele leads to deletion efficiencies of
83–99% in mature granulocytes of floxed alleles [14]. PCR
analysis of genomic DNA from peritoneal neutrophils from
FLNa null (females: FLNac/-LysMcre/+ or males: FLNac/yLysMcre/+)
mice demonstrated near complete conversion of the conditional
allele into the null allele (Figure 1A). A faint wild type band is
noted in the Cre-recombinase samples. Western blot analysis
of protein from pertitoneal neutrophils from FLNa null mice also
demonstrates a faint residual FLNa band following incubation
with a FLNa antibody (Figure 1B). This is likely due to a
combination of minor cell contamination from peritoneal
preparations and a small percentage of cells that did not
undergo recombinase mediated deletion of the FLNa gene [14].
In order to assess FLNa protein expression in the null cells,
Western blot analysis using rFLNa as a standard demonstrated
that ~40, 000 wild-type neutrophils contain (53.97 ± 2.76 ng ) of
FLNa and the same number of FLNa null (FLNac/-LysMcre/+)
neutrophils showed 6.09 ng ± 0.80 ng of FLNa (Figure 2 A,
Table 1). Since recombination mediated by Cre recombinase
either occurs or does not occur, the neutrophils will either have
no FLNa expression or will have normal FLNa expression
levels. As described previously and shown here (Figure 1A),
The LysM Cre mouse eliminates the flanked loxP DNA in at
least 88% of neutrophils [14]. It is likely higher as the residual
FLNa protein detected in the Western blots results from a
combination of non-neutrophil cell contamination as our
isolation procedure has ~5% contamination of other cell types
suggesting that only a small fraction (~7%) of neutrophils retain
FLNa expression.
Figure 2.  Standard Curve of FLNa and FLNb.  (A) FLNa and
(B) FLNb standard curves were created by loading known
amount of FLNa (5, 10, 20, 40ng) and FLNb ( 2, 4, 6, 8ng) in to
7.5% SDA-PAGE gels along with 40 thousand neutrophils from
WT (Yellow) and FLNa null (Pink) mice. Densitometry of the
blots was correlated with the amount of protein. (N=3-5). (C)
The concentration of FLNa and FLNb in wild type and FLNa
null neutrophils. The change in each protein between WT and
Null cells is noted.
doi: 10.1371/journal.pone.0079009.g002
Upregulation of Filamin-B does not compensate for
FLNa deficiencies
To determine if the FLNb isoform was compensating for the
loss of FLNa, the levels of FLNb expression were measured in
the control and FLNa null cells. Protein levels from Western
blots of the wild-type and FLNa-null neutrophils were applied to
the standard curve that was created using known amounts of
FLNb antigen to determine the total amount of FLNb protein
present in the neutrophils. In the absence of the FLNa protein
expression, neutrophils show a significant 2-fold increase in
FLNb protein expression compared to wild-type neutrophils
(Figure 2B,Table 1).
FLNa is required for tail retraction
Previous studies with FLNa-deficient melanoma cells show
that FLNa is required for cell polarization and migration toward
a chemoattractant [8]. We observed that neutrophils deficient in
FLNa, are able to polarize and undergo chemotaxis in
response to an fMLP stimulus in a similar manner to WT
neutrophils (Figure 3A, B, C). A Zigmond chamber chemotaxis
assay was used to measure both chemokinesis (100nm) and
chemotaxis. These experiments revealed that FLNa null
neutrophils demonstrate significantly diminished chemokinesis
speeds compared with wild-type neutrophils (Figure 3 E, G, I).
FLNa null neutrophils also displayed significantly reduced
speeds compared with WT neutrophils in the chemotactic
gradient, although the moderate amount of migration that did
occur in the FLNa null cells resulted in translocation toward the
chemoattractant source (Figure 3 D, F, H). The reduced speed
for FLNa null neutrophils was maintained over 30 minutes of
migration toward fMLP (data not shown). To confirm that this
phenotype was maintained in vivo, a peritonitis model showed
that FLNa deficient neutrophils displayed reduced
accumulation during an acute inflammatory response (Figure
4). To characterize the tail retraction defect, we measured the
average neutrophil length after 15 minutes and the average
change in neutrophil length over 10 minutes. Both analyses
showed that the FLNa null cells displayed a mean length more
than double the WT neutrophils (Figure 3A2, A3). To rule out
the possibility of lysMCre being involved in the neutrophil
phenotype, in vivo and in vitro chemotaxis assays showed no
difference between lysMCre lacking and expressing
neutrophils. (data not shown).
FLNa regulates neutrophil RhoA activity in the uropod
Since FLNa null neutrophils exhibited poor tail retraction, we
assessed the role of FLNa in the activation of the small RhoA
small GTPase following fMLP (10-6M) stimulation. Western blot
Table 1.
Protein (ng/
cell) WT FLNa null
Percent Change
from WT to FLNa
FLNa 1.35 x10-3±1.54x10-4 1.52 x10-4±5.28x10-5 -89%
FLNb 9.60x10-6±4.03x10-6 2.09 x10-5±1.43x10-6 +54%
doi: 10.1371/journal.pone.0079009.t001
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Figure 3.  FLNa alters cell translocation but not
polarization (A).  WT and FLNa null neutrophils show similar
pseudopod extension in the fMLP gradient, however the FLNa
cells show poor tail retraction. (* trailing uropod). (A2) The
mean length of neutrophils after 15 minutes of fMLP. (A3) The
average length of neutrophils during10 minutes of fMLP
stimulation. n= 90 cells (B) Lack of cell polarization without
fMLP after 20 minutes. (C) FLNa null cells show no deficiency
in fMLP mediated polarization. (D, F, H) Chemotaxis: FLNa null
cells migrate toward fMLP (towards right) slower than WT cells
(E, G, I) Chemokinesis: FLNa null cells show reduced speed/
translocation during chemotaxis compared to WT cells. Bar
diagrams represent the average of 3 independent experiments
± SD. *P < .05 ** P < .01.
doi: 10.1371/journal.pone.0079009.g003
Figure 4.  FLNa required for recruitment to peritoneum
(A).  Neutrophil Peritoneal Recruitment: FLNa null mice display
reduced neutrophil peritonitis induced recruitment.
doi: 10.1371/journal.pone.0079009.g004
analyses of total cellular extracts showed that the levels of
active RhoA was significantly reduced in both attached FLNa
null neutrophils (by 83% at 60 sec and 300 sec of fMLP
stimulation) and those in suspension (by 53% at 60 sec and
59% at 300 sec of fMLP stimulation) when compared to wild-
type controls (Figure 5A, B). Conversely, the activation levels
of the small GTPases, Rac1 and cdc42, were undisturbed in
FLNa null neutrophils compared to wild-type cells (Figure 5C,
D). To further verify FLNa regulation of Rho A in the uropod,
subcellular localization of FLNa and Rho A were investigated.
Fluorescence microscopy images displayed the abundant
FLNa and Rho A at the uropod in WT cells, but an absence of
Rho A in the uropod in FLNa deficient cells (Figure 6C, D).
Filamin-A regulates Myosin II–mediated contractility
through Rho in the uropod
In order to determine whether the FLNa-dependent activation
of RhoA could account for the observed tail retraction defect,
Figure 5.  Rho A activity is reduced in FLNa null cells.  WT
and FLNa null neutrophils in suspension (A) or plated on
dishes (B) for 20 minutes are stimulated with 1μM fMLP for 30,
60, and 300 seconds. GTP-RhoA is detected by immunoblot
assay. Immunoblot and densitometry analysis shows a
decrease of active RhoA in FLNa null neutrophils over a 300
sec time-frame compared to wild-type cells. (C) cdc42 and (D)
Rac1 activities in FLNa null cells: FLNa null cells show no
defect in cdc42 and Rac1 activation as seen in Rho. Bar
diagrams represent the average of 3 independent experiments
± SD. ** P < 0.01.
doi: 10.1371/journal.pone.0079009.g005
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we determined the localization and activation state of myosin
light chain 2 using an antibody to phosphorylated (Ser19)
myosin regulatory light chain 2. Myosin has been previously
shown to function in uropod retraction through its role in
regulating actin filament contraction [22,23]. In murine
neutrophils, we observed that cells without FLNa displayed a
significant inhibition of normal fMLP-mediated increase in
myosin light chain 2 phosphorylation in the neutrophils (Figure
6A). Overall levels of myosin light chain 2 phosphorylated at
Ser19 were decreased by more than 84% in FLNa null cells,
while the overall activation of myosin, as measured by myosin
light chain 2 phosphorylation at Ser19, was significantly
increased in fMLP stimulated wild-type neutrophils.
Immunolocalization of phospho- myosin light chain 2 in fMLP-
activated mouse neutrophils demonstrated localization to the
uropod in WT cells, but absence in the uropod of FLNa-null
cells (Figure 6B).
Figure 6.  FLNa regulates localization of p-Myosin Light
Chain-2 (p-MLC2) and Rho A in the uropod.  (A) Reduced p-
MLC2 levels in FLNa null neutrophils. Immunoblot analysis
shows a significant reduction in p-MLC2 in FLNa null
neutrophils following 120sec of fMLP (10-6) compared to WT
levels. Mean ± SD of four mice per group. * significance of p< .
05 within a group and (**) significance of p<.05 between groups
(B) p-MLC2 is absent in the tails of FLNa null neutrophils after
stimulation with fMLP at 120s. C) Rho A is absent in the tails of
FLNa null neutrophils following fMLP stimulation at120s. (D)
FLNa primarily localizes to the tail of wild type neutrophils after
fMLP stimulation at 120s.
doi: 10.1371/journal.pone.0079009.g006
Neutrophil-substrate adhesiveness depend on FLNa
To investigate the role FLNa in neutrophil-substrate
adhesion, we compared the percentage of cells remaining
attached after a shear force applied to 96-well plates that were
coated with different integrin ligands. The results showed that
FLNa deficient cells had a significant increase in adhesiveness
to substrates coated with BSA, fibronectin and fibrinogen
(Figure 7).
Discussion
FLNa was first identified as the prototypic actin binding
protein. However in recent years it has been recognized that
this important actin binding and filament cross-linking protein
has numerous binding sites for signaling proteins and may play
important roles in a number of signal transduction cascades
[5,24]. In this study, we investigated the role of FLNa in
neutrophil chemotaxis. Using primary neutrophils derived from
a murine transgenic conditional FLNa knock-out mouse, we
show that FLNa regulates cell locomotion efficiency through its
role in activation of RhoA-myosin mediated uropod retraction.
FLNa and chemotaxis
Previous studies looking into FLNa’s role in directed cell
migration (chemotaxis) have been carried out primarily in a
human melanoma cell line lacking FLNa. These experiments
supported the role of FLNa in the early phases of cell
migration. These melanoma cells have been shown to be
incapable of polarization and locomotion due to their inability to
regulate and stabilize their cortical actin cytoskeleton which
manifests as continuous circumferential surface blebbing [8].
Neutrophils are a commonly used cell model for studying
chemotaxis, due to the distinct cell polarization that results in a
well-defined leading edge and a characteristic tail or uropod.
Figure 7.  FLNa regulates neutrophil-substrate
adhesiveness.  FLNa deficiency increases neutrophil-
substrate adhesion. The number of cells was counted prior to
plate inversion and spinning at33 RCF. The wells are rinsed
with PBS and the total number of cells counted again. The
percentage of cells attached after spinning were calculated.
Three independent experiments were carried out. Error bars
are ± SD. **p< .01.
doi: 10.1371/journal.pone.0079009.g007
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We have shown here that neutrophils lacking FLNa are able to
polarize normally and migrate up a chemoattractant gradient;
however, they are unable to retract their uropod resulting in an
elongated cell body during chemotaxis. This data appears to be
inconsistent with previous melanoma cell work in this area and
suggests that FLNa is not essential at the leading edge of
migrating neutrophils.
This inconsistency can be explained by the possibility that in
FLNa null neutrophils, FLNb may be partially capable of
compensating for the lack of FLNa. In particular, this may be
true at the front of the cell, where FLNa is essential for actin
crosslinking during polarization and leading edge extension.
This explanation is not unreasonable, as several other cell lines
including fibroblasts, vascular endothelial cells and neural crest
cells exhibit normal filamentous actin (F-Actin) structure,
motility, and locomotion in the absence of FLNa, leading the
authors to question FLNa’s role in F-actin polymerization and
cross-linking while also not ruling out the possibility that FLNb
and FLNc may compensate for FLNa to maintain motility in
these cells [13,25,26]. It is important to note that despite the
observed increase in FLNb levels, the total amount of this
protein present in the FLNa null cells is small, on the order of
66X’s less, in comparison to the levels of FLNa normally
present in neutrophils. However, it may be possible, that FLNb
is sufficiently concentrated at the leading of the cell to replace
FLNa levels there but unable to replace FLNa in the uropod to
activate RhoA during chemotaxis. Unfortunately an antibody for
FLNb immunolocalization is not available to test this
hypothesis.
FLNa and RhoA
Neutrophil chemotaxis is dependent on the establishment
and maintenance of cell polarity. A well-defined leading edge
and uropod requires the localization and activation of specific
Rho GTPases. Unlike Cdc42 and Rac which localize to and are
responsible for the formation and protrusion of the leading
edge, RhoA localizes to and is responsible for regulating the
myosin II-based contraction and retraction of the trailing uropod
[27,28]. Our data shows RhoA is in both the leading edge and
uropod in WT cells but only in the leading edge of the FLNa
null cells. While Pertz et al. [29] observed that RhoA is primarily
found in the leading edge of fibroblasts, previous work from our
lab has shown that RhoA does also localize to the uropod of
neutrophils [12] and is required for normal cell migration.
In muscle and non-muscle cells, the activation of Myosin-II is
primarily through the phosphorylation of the myosin light chain
at serine 19 [22,29]. The actin based myosin motor at the rear
of the cell is essential for tail retraction and can be activated
through two separate pathways. The first requires intracellular
calcium, which binds calmodulin and activates myosin light
chain kinase, which then directly phosphorylates and activates
the myosin binding subunit of the myosin regulatory light chain
[30]. The second also involves the myosin light chain, which
can be activated through the small GTPase RhoA pathway.
When RhoA is active in the rear of the cell, it phosphorylates
and activates Rho-kinase (ROCK), which can either directly
phosphorylate and activate the myosin binding subunit of
myosin light chain or can phosphorylate and inactivate myosin
phosphatase, preventing myosin phosphatase from
dephosphorylating and inactivating the myosin light chain. In
addition to the localization and activation of RhoA and MLC in
the uropod, a neutrophil must also break the newly formed
adhesive contacts with the substratum at the rear of the cell to
allow the actinomyosin motor to retract the tail and maintain
persistent forward motility. Myosin light chain kinase-inhibited
neutrophils show a similar tail retraction defect to the FLNa null
cells, where a thin region of non-retractable membrane at the
uropod remains tightly anchored to the substratum and often
became elongated as the cell extended a new leading edge
forward [31]. These studies illustrate that FLNa mediates RhoA
activation in chemotaxing neutrophils. Potential Rho regulatory
mechanisms to explore involve RhoA GEFs and GAPs
including RhoGEF Lbc or TRIO. In addition to manipulating the
activation state of RhoA, these two proteins have been shown
to interact with FLNa, making them worthwhile candidates to
explore further.
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